Vitamin D Status, Cardiovascular Risk Profile, and miRNA-21 Levels in Hypertensive Patients: Results of the HYPODD Study

The vitamin D and microRNA (miR) systems may play a role in the pathogenesis of cardiometabolic disorders, including hypertension. The HYPODD study was a double-blind placebo-controlled trial aiming to assess the effects of cholecalciferol treatment in patients with well-controlled hypertension and...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Nutrients 2022-06, Vol.14 (13), p.2683
Hauptverfasser:	Rendina, Domenico, D Elia, Lanfranco, Abate, Veronica, Rebellato, Andrea, Buondonno, Ilaria, Succoio, Mariangela, Martinelli, Fabio, Muscariello, Riccardo, De Filippo, Gianpaolo, D Amelio, Patrizia, Fallo, Francesco, Strazzullo, Pasquale, Faraonio, Raffaella
Format:	Artikel
Sprache:	eng
Schlagworte:	Calciferol Calcitriol Calcitriol - therapeutic use Cardiovascular disease Cardiovascular diseases Cardiovascular Diseases - drug therapy Cholecalciferol - pharmacology Cholecalciferol - therapeutic use Cholesterol Clinical trials Coronary vessels Dietary Supplements Double-Blind Method Ethanol Evaluation Gene expression Health risks Heart Disease Risk Factors Heart failure HEK293 Cells Humans Hypertension Hypertension - drug therapy MicroRNAs miRNA Pathogenesis Patients Placebos Risk assessment Risk Factors Vein & artery diseases Vitamin D Vitamin D - therapeutic use Vitamin D Deficiency - drug therapy Vitamin deficiency Vitamins
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!